1.89 USD
+0.01 (+0.53%)
ChartMill assigns a Buy % Consensus number of 86% to IBIO. The Buy consensus is the weighted average rating of the current analysts ratings.
IBIO was analyzed by 10 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about IBIO.
In the previous month the buy percentage consensus was at a similar level.
IBIO was analyzed by 10 analysts. More opinions would make the average more meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-21 | Oppenheimer | Initiate | Outperform |
| 2025-10-17 | Leerink Partners | Initiate | Outperform |
| 2025-06-25 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-06 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-05 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-12-17 | LUCID CAPITAL MARKETS | Initiate | Buy |
| 2024-07-22 | Brookline Capital | Initiate | Buy |
| 2024-06-03 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-05-28 | Chardan Capital | Initiate | Buy |
| 2023-02-16 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2022-10-07 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2021-11-29 | JMP Securities | Initiate | Outperform |
IBIO INC / IBIO FAQ
What is the consensus rating for IBIO stock?
The consensus rating for IBIO INC (IBIO) is 86 / 100 . This indicates that analysts generally have a positive outlook on the stock.